Citrus nobiletin inhibits azoxymethane-induced large bowel carcinogenesis in rats

BioFactors

Volumn 21, Issue 1-4, 2004, Pages 111-114

  Suzuki, Rikako ^a,b   Kohno, Hiroyuki ^a   Murakami, Akira ^c   Koshimizu, Koichi ^c   Ohigashi, Hajime ^c   Yano, Masamichi ^d   Tokuda, Harukuni ^e   Nishino, Hoyoku ^e   Tanaka, Takuji ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF FRUIT TREE SCIENCE   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Colon carcinogenesis; Inhibition; Nobiletin; Rats

Indexed keywords

AZOXYMETHANE; NOBILETIN; PROSTAGLANDIN E2; ANTINEOPLASTIC AGENT; CYCLINE; FLAVONE DERIVATIVE; POLYAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BIOASSAY; CANCER INCIDENCE; CELL ACTIVITY; CELL PROLIFERATION; CITRUS FRUIT; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLON MUCOSA; COLON TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; DIETARY INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FISCHER 344 RAT; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHYTOTHERAPY;

CITRUS;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; AZOXYMETHANE; CITRUS; COLONIC NEOPLASMS; DINOPROSTONE; FLAVONES; INTESTINAL MUCOSA; MALE; PHYTOTHERAPY; POLYAMINES; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344;

EID: 21644461801     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.552210121     Document Type: Conference Paper

References (13)

1. A. Bennett, A. Civier, C.N. Hensby, P.B. Melhuish and I.F. Stamford, Gut 28 (1987), 315-318.
2. J. Chen, A.M. Montanari and W.W. Widmer, J. Agric. Food Chem. 45 (1997), 364-368.
3. M. Cuendet and J.M. Pezzuto, Drug Metabol. Drug Interact. 17 (2000), 109-157.
4. C. Kandaswami, E. Perkins, D.S. Soloniuk, G. Drzewiecki and E.J. Middleton, Cancer Lett. 56 (1991), 147-152.
5. H. Kohno, S. Yoshitani, Y. Tsukio, A. Murakami, K. Koshimizu, M. Yano, H. Tokuda, H. Nishino, H. Ohigashi and T. Tanaka, Life Sci. 69 (2001), 901-913.
6. T. Koide, S. Sakai, Y. Kawada, A. Hara and H. Sawada, Acta Urol. Jpn. 36 (1990), 1103-1108.
7. N.K. Mak, Y.L. Wong-Leung, S.C. Chan, J. Wen, K.N. Leung and M.C. Fung, Life Sci. 58 (1996), 1269-1976.
8. A. Minagawa, Y. Otani, T. Kubota, N. Wada, T. Furukawa, K. Kumai, K. Kameyama, Y. Okada, M. Fujii, M. Yano, T. Sato, A. Ito and M. Kitajima, Jpn. J. Cancer Res. 92 (2001), 1322-1328.
9. A. Murakami, Y. Nakamura, T. Tanaka, H. Tokuda, H. Nishino, S. Kuwahara, Y. Takahashi, K. Ogawa, M. Yano, T. Koshiba, K. Koshimizu, K. Torikai and H. Ohigashi, Cancer Res. 60 (2000), 5059-5066.
10. T. Sato, L. Koike, Y. Miyata, M. Hirata, Y. Mimaki, Y. Sashida, M. Yano and A. Ito, Cancer Res. 62 (2002), 1025-1029.
11. V.E. Steele, C.A. Holmes, E.T. Hawk, L. Kopelovich, R.A. Lubet, J.A. Crowell, C.C. Sigman and G.J. Kelloff, Cancer Epidemiol. Biomarkers Prev. 8 (1999), 467-483.
12. M.W. Wall, M.C. Wani, G. Manukumar, P. Abraham, H. Taylor, T.J. Hughes, J. Warner and R. McGivney, J. Nat. Prod. 51 (1998), 1084-1091.
13. Q. Zheng, Y. Hirose, N. Yoshimi, A. Murakami, K. Koshimizu, H. Ohigashi, K. Sakata, Y. Matsumoto, S.Y. and H. Mori, J. Cancer Res. Clin. Oncol. 128 (2002), 539-546.